文献速递新发突发、热带与寄生虫病医院感染防控

美国孕妇SARS-CoV-2感染发病率、临床特征及危险因素

Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States.
PubMed 文献 · Clin Infect Dis · 2022-01-01

该前瞻性队列研究于2020年8月至2021年3月在美国3个中心随访1098名孕妇,平均随访10周,任何SARS-CoV-2感染的人群加权发病率为每1000人周10.0例,有症状感染为5.7例,无症状感染为3.5例。研究结论强调在社区SARS-CoV-2流行期间孕妇每周感染风险约1%,应重视疫苗接种等预防措施。

要点

  • 孕妇SARS-CoV-2任何感染的人群加权发病率为每1000人周10.0例。
  • 有症状和无症状感染发病率分别为每1000人周5.7例和3.5例。
  • 常见症状为鼻塞、咳嗽、头痛和味嗅觉改变,中位症状持续10天。

核心结论

  • 孕妇在SARS-CoV-2社区流行期间每周感染风险约1%,应重视疫苗接种和其他预防措施。

研究设计与样本

  • 前瞻性队列研究,2020年8月至2021年3月在美国3个中心随访1098名孕妇,平均随访10周。

主要发现

  • 1098名孕妇中9%(99/1098)在研究期间感染SARS-CoV-2。
  • 任何感染的人群加权发病率为每1000人周10.0例(95%CI 5.7-14.3)。
  • 有症状感染发病率为每1000人周5.7例(95%CI 1.7-9.7),无症状感染为3.5例(95%CI 0-7.1)。
  • 96名有症状数据感染者中,常见症状为鼻塞(72%)、咳嗽(64%)、头痛(59%)、味嗅觉改变(54%),28%有发热。
  • 中位症状持续时间为10天(IQR 6-16)。

临床怎么用

  • 在SARS-CoV-2社区流行期间,应告知孕妇每周感染风险约1%,并推荐接种COVID-19疫苗及采取其他预防措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data about the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among pregnant individuals are needed to inform infection-prevention guidance and counseling for this population. METHODS: We prospectively followed a cohort of pregnant individuals during August 2020-March 2021 at 3 US sites. The 3 primary outcomes were incidence rates of any SARS-CoV-2 infection, symptomatic infection, and asymptomatic infection, during pregnancy during periods of SARS-CoV-2 circulation. Participants self-collected weekly midturbinate nasal swabs for SARS-CoV-2 reverse transcription-polymerase chain reaction testing, completed weekly illness symptom questionnaires, and submitted additional swabs with coronavirus disease 2019 (COVID-19)-like symptoms. An overall SARS-CoV-2 infection incidence rate weighted by population counts of women of reproductive age in each state was calculated. RESULTS: Among 1098 pregnant individuals followed for a mean of 10 weeks, 9% (99/1098) had SARS-CoV-2 infections during the study. Population-weighted incidence rates of SARS-CoV-2 infection were 10.0 per 1000 (95% confidence interval, 5.7-14.3) person-weeks for any infection, 5.7 per 1000 (1.7-9.7) for symptomatic infections, and 3.5 per 1000 (0-7.1) for asymptomatic infections. Among 96 participants with SARS-CoV-2 infections and symptom data, the most common symptoms were nasal congestion (72%), cough (64%), headache (59%), and change in taste or smell (54%); 28% had measured or subjective fever. Median symptom duration was 10 (interquartile range, 6-16) days. CONCLUSIONS: Pregnant individuals in this study had a 1% risk of SARS-CoV-2 infection per week, underscoring the importance of COVID-19 vaccination and other prevention measures during pregnancy while SARS-CoV-2 is circulating in the community.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dawood FS, Varner M, Tita A, et al. Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States. Clin Infect Dis. 2022. PMID: 34410340. doi:10.1093/cid/ciab713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。